Tikva Allocell
News,Biotech / MedTech,Singapore
Singapore’s Tikva Allocell raises $8M in Series A financing led by Kantharos Capital
Tikva Allocell Pte. Ltd. (Tikva), a Singapore-based biotechnology company, has on Wednesday announced the closing of an $8 million Series A financing led by Kantharos Capital.
July 23, 2026
Firmus scraps A$7 billion Australian IPO
October 9, 2026
TSMC quarterly revenue hits record NT$1.49 trillion
October 9, 2026
Firmus scraps A$7 billion Australian IPO
October 9, 2026
TSMC quarterly revenue hits record NT$1.49 trillion
October 9, 2026




